Friday, October 3, 2008

In U.S., Amgen Won’t Face Competition from Roche for Anemia Drugs

A federal court finally prohibited Roche from sell its drug Mircera in the U.S. The drug would have competed with Amgen's Epogen and Aranesp.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)